Lung cancer - small cell and Rheumatoid arthritis

Summary:

Rheumatoid arthritis is reported only by a few people with Lung cancer - small cell.

The study analyzes which people have Rheumatoid arthritis with Lung cancer - small cell. It is created by eHealthMe based on 4 people who have Rheumatoid arthritis and Lung cancer - small cell from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 02, 2022

4 people who have Lung Cancer - Small Cell and Rheumatoid Arthritis are studied.


What is Lung cancer - small cell?

Lung cancer - small cell (lung cancer) is found to be associated with 662 drugs and 441 conditions by eHealthMe.

What is Rheumatoid arthritis?

Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints) is found to be associated with 2,768 drugs and 1,983 conditions by eHealthMe.

Number of Rheumatoid arthritis in Lung cancer - small cell reports submitted per year:

Would you have Rheumatoid arthritis when you have Lung cancer - small cell?

Gender of people who have Lung Cancer - Small Cell and experienced Rheumatoid Arthritis *:

  • female: 25 %
  • male: 75 %

Age of people who have Lung Cancer - Small Cell and experienced Rheumatoid Arthritis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 25 %
  • 60+: 75 %

Common co-existing conditions for these people *:

  1. Insomnia (sleeplessness): 1 person, 25.00%
  2. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 25.00%

Common drugs taken by these people *:

  1. Paxil: 1 person, 25.00%
  2. Lansoprazole: 1 person, 25.00%
  3. Imfinzi: 1 person, 25.00%
  4. Etoposide: 1 person, 25.00%
  5. Difluprednate: 1 person, 25.00%
  6. Carboplatin: 1 person, 25.00%
  7. Calcium: 1 person, 25.00%
  8. Alimta: 1 person, 25.00%

Common symptoms for these people *:

  1. Skin Exfoliation (removal of the oldest dead skin cells): 1 person, 25.00%
  2. Presyncope: 1 person, 25.00%
  3. Peripheral Swelling: 1 person, 25.00%
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 1 person, 25.00%
  5. Joint Pain: 1 person, 25.00%
  6. Constipation: 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Rheumatoid arthritis?

Check whether Rheumatoid arthritis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Rheumatoid arthritis:

Common drugs associated with Rheumatoid arthritis:

All the drugs that are associated with Rheumatoid arthritis:

Common conditions associated with Rheumatoid arthritis:

All the conditions that are associated with Rheumatoid arthritis:

How the study uses the data?

The study is based on Rheumatoid arthritis and Lung cancer - small cell, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: